Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Lung cancer and socioeconomic status in a pooled analysis of case-control studies

J. Hovanec, J. Siemiatycki, DI. Conway, A. Olsson, I. Stücker, F. Guida, KH. Jöckel, H. Pohlabeln, W. Ahrens, I. Brüske, HE. Wichmann, P. Gustavsson, D. Consonni, F. Merletti, L. Richiardi, L. Simonato, C. Fortes, ME. Parent, J. McLaughlin, P....

. 2018 ; 13 (2) : e0192999. [pub] 20180220

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, metaanalýza, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024347

BACKGROUND: An association between low socioeconomic status (SES) and lung cancer has been observed in several studies, but often without adequate control for smoking behavior. We studied the association between lung cancer and occupationally derived SES, using data from the international pooled SYNERGY study. METHODS: Twelve case-control studies from Europe and Canada were included in the analysis. Based on occupational histories of study participants we measured SES using the International Socio-Economic Index of Occupational Status (ISEI) and the European Socio-economic Classification (ESeC). We divided the ISEI range into categories, using various criteria. Stratifying by gender, we calculated odds ratios (OR) and 95% confidence intervals (CI) by unconditional logistic regression, adjusting for age, study, and smoking behavior. We conducted analyses by histological subtypes of lung cancer and subgroup analyses by study region, birth cohort, education and occupational exposure to known lung carcinogens. RESULTS: The analysis dataset included 17,021 cases and 20,885 controls. There was a strong elevated OR between lung cancer and low SES, which was attenuated substantially after adjustment for smoking, however a social gradient persisted. SES differences in lung cancer risk were higher among men (lowest vs. highest SES category: ISEI OR 1.84 (95% CI 1.61-2.09); ESeC OR 1.53 (95% CI 1.44-1.63)), than among women (lowest vs. highest SES category: ISEI OR 1.54 (95% CI 1.20-1.98); ESeC OR 1.34 (95% CI 1.19-1.52)). CONCLUSION: SES remained a risk factor for lung cancer after adjustment for smoking behavior.

Cancer Care Ontario Occupational Cancer Research Centre Toronto Canada

Dental School College of Medicine Veterinary and Life Sciences University of Glasgow Glasgow United Kingdom

Environmental Epidemiology Division Institute for Risk Assessment Sciences Utrecht University Utrecht The Netherlands

Epidemiology Unit Istituto Dermopatico dell'Immacolata Rome Italy

INRS Institut Armand Frappier Université du Québec Laval Québec Canada

Inserm Centre for Research in Epidemiology and Population Health U1018 Environmental Epidemiology of Cancer Team Villejuif France University Paris Sud UMRS 1018 Villejuif France

Institute for Medical Informatics Biometry and Epidemiology University Hospital Essen Essen Germany

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance Institute of the Ruhr Universität Bochum Bochum Germany

Institute of Carcinogenesis Russian Cancer Research Centre Moscow Russia

Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

Institute of Epidemiology 1 Helmholtz Zentrum München Neuherberg Germany

Institute of Epidemiology 1 Helmholtz Zentrum München Neuherberg Germany Institute of Medical Statistics and Epidemiology Technical University Munich Munich Germany

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

International Agency for Research on Cancer Lyon France

International Agency for Research on Cancer Lyon France Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

Laboratory of Public Health and Population Studies Department of Molecular Medicine University of Padova Padova Italy

Leibniz Institute for Prevention Research and Epidemiology BIPS GmbH Bremen Germany

Leibniz Institute for Prevention Research and Epidemiology BIPS GmbH Bremen Germany Institute for Statistics University Bremen Bremen Germany

Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University Dept of Cancer Epidemiology and Genetics Brno Czech Republic

Molecular Epidemiology of Cancer Unit University of Oviedo Ciber de Epidemiologia CIBERESP Oviedo Spain

National Cancer Institute Division of Cancer Epidemiology and Genetics Bethesda United States of America

National Centre for Public Health Budapest Hungary

National Institute of Public Health Bucharest Romania

Palacky University Faculty of Medicine Olomouc Czech Republic Department of Epidemiology and Public Health Faculty of Medicine University of Ostrava Ostrava Czech Republic

Public Health Ontario Toronto Canada

Regional Authority of Public Health Preventive Occupational Medicine Banska Bystrica Slovakia

Roy Castle Lung Cancer Research Programme Cancer Research Centre University of Liverpool Liverpool United Kingdom

The M Sklodowska Curie Cancer Center and Institute of Oncology Warsaw Poland

The Nofer Institute of Occupational Medicine Lodz Poland

The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York New York United States of America

Unit of Cancer Epidemiology Department of Medical Sciences University of Turin Turin Italy

Unit of Epidemiology Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

University of Montreal Hospital Research Center and School of Public Health Montreal Canada

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024347
003      
CZ-PrNML
005      
20180710092714.0
007      
ta
008      
180709s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0192999 $2 doi
035    __
$a (PubMed)29462211
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hovanec, Jan $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany.
245    10
$a Lung cancer and socioeconomic status in a pooled analysis of case-control studies / $c J. Hovanec, J. Siemiatycki, DI. Conway, A. Olsson, I. Stücker, F. Guida, KH. Jöckel, H. Pohlabeln, W. Ahrens, I. Brüske, HE. Wichmann, P. Gustavsson, D. Consonni, F. Merletti, L. Richiardi, L. Simonato, C. Fortes, ME. Parent, J. McLaughlin, P. Demers, MT. Landi, N. Caporaso, A. Tardón, D. Zaridze, N. Szeszenia-Dabrowska, P. Rudnai, J. Lissowska, E. Fabianova, J. Field, RS. Dumitru, V. Bencko, L. Foretova, V. Janout, H. Kromhout, R. Vermeulen, P. Boffetta, K. Straif, J. Schüz, B. Kendzia, B. Pesch, T. Brüning, T. Behrens,
520    9_
$a BACKGROUND: An association between low socioeconomic status (SES) and lung cancer has been observed in several studies, but often without adequate control for smoking behavior. We studied the association between lung cancer and occupationally derived SES, using data from the international pooled SYNERGY study. METHODS: Twelve case-control studies from Europe and Canada were included in the analysis. Based on occupational histories of study participants we measured SES using the International Socio-Economic Index of Occupational Status (ISEI) and the European Socio-economic Classification (ESeC). We divided the ISEI range into categories, using various criteria. Stratifying by gender, we calculated odds ratios (OR) and 95% confidence intervals (CI) by unconditional logistic regression, adjusting for age, study, and smoking behavior. We conducted analyses by histological subtypes of lung cancer and subgroup analyses by study region, birth cohort, education and occupational exposure to known lung carcinogens. RESULTS: The analysis dataset included 17,021 cases and 20,885 controls. There was a strong elevated OR between lung cancer and low SES, which was attenuated substantially after adjustment for smoking, however a social gradient persisted. SES differences in lung cancer risk were higher among men (lowest vs. highest SES category: ISEI OR 1.84 (95% CI 1.61-2.09); ESeC OR 1.53 (95% CI 1.44-1.63)), than among women (lowest vs. highest SES category: ISEI OR 1.54 (95% CI 1.20-1.98); ESeC OR 1.34 (95% CI 1.19-1.52)). CONCLUSION: SES remained a risk factor for lung cancer after adjustment for smoking behavior.
650    _2
$a věkové faktory $7 D000367
650    _2
$a senioři $7 D000368
650    _2
$a Kanada $7 D002170
650    _2
$a Evropa $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a logistické modely $7 D016015
650    _2
$a nádory plic $x epidemiologie $x patologie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pracovní expozice $7 D016273
650    _2
$a odds ratio $7 D016017
650    _2
$a rizikové faktory $7 D012307
650    _2
$a sexuální faktory $7 D012737
650    _2
$a kouření $x epidemiologie $7 D012907
650    _2
$a společenská třída $7 D012923
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Siemiatycki, Jack $u University of Montreal, Hospital Research Center (CRCHUM) and School of Public Health, Montreal, Canada.
700    1_
$a Conway, David I $u Dental School, College of Medicine Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
700    1_
$a Olsson, Ann $u International Agency for Research on Cancer (IARC), Lyon, France. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Stücker, Isabelle $u Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Team, Villejuif, France. University Paris-Sud, UMRS 1018, Villejuif, France.
700    1_
$a Guida, Florence $u Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Team, Villejuif, France. University Paris-Sud, UMRS 1018, Villejuif, France.
700    1_
$a Jöckel, Karl-Heinz $u Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.
700    1_
$a Pohlabeln, Hermann $u Leibniz-Institute for Prevention Research and Epidemiology -BIPS GmbH, Bremen, Germany.
700    1_
$a Ahrens, Wolfgang $u Leibniz-Institute for Prevention Research and Epidemiology -BIPS GmbH, Bremen, Germany. Institute for Statistics, University Bremen, Bremen, Germany.
700    1_
$a Brüske, Irene $u Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, Germany.
700    1_
$a Wichmann, Heinz-Erich $u Institute of Epidemiology I, Helmholtz Zentrum München, Neuherberg, Germany. Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, Germany.
700    1_
$a Gustavsson, Per $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Consonni, Dario $u Unit of Epidemiology, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
700    1_
$a Merletti, Franco $u Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.
700    1_
$a Richiardi, Lorenzo $u Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.
700    1_
$a Simonato, Lorenzo $u Laboratory of Public Health and Population Studies, Department of Molecular Medicine, University of Padova, Padova, Italy.
700    1_
$a Fortes, Cristina $u Epidemiology Unit, Istituto Dermopatico dell'Immacolata (IDI-IRCCS-FLMM), Rome, Italy.
700    1_
$a Parent, Marie-Elise $u INRS-Institut Armand-Frappier, Université du Québec, Laval, Québec, Canada.
700    1_
$a McLaughlin, John $u Public Health Ontario, Toronto, Canada.
700    1_
$a Demers, Paul $u Cancer Care Ontario, Occupational Cancer Research Centre, Toronto, Canada.
700    1_
$a Landi, Maria Teresa $u National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, United States of America.
700    1_
$a Caporaso, Neil $u National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, United States of America.
700    1_
$a Tardón, Adonina $u Molecular Epidemiology of Cancer Unit, University of Oviedo-Ciber de Epidemiologia, CIBERESP, Oviedo, Spain.
700    1_
$a Zaridze, David $u Institute of Carcinogenesis, Russian Cancer Research Centre, Moscow, Russia.
700    1_
$a Szeszenia-Dabrowska, Neonila $u The Nofer Institute of Occupational Medicine, Lodz, Poland.
700    1_
$a Rudnai, Peter $u National Centre for Public Health, Budapest, Hungary.
700    1_
$a Lissowska, Jolanta $u The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.
700    1_
$a Fabianova, Eleonora $u Regional Authority of Public Health, Preventive Occupational Medicine, Banska Bystrica, Slovakia.
700    1_
$a Field, John $u Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom.
700    1_
$a Dumitru, Rodica Stanescu $u National Institute of Public Health, Bucharest, Romania.
700    1_
$a Bencko, Vladimir $u Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Foretova, Lenka $u Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Dept. of Cancer Epidemiology & Genetics, Brno, Czech Republic.
700    1_
$a Janout, Vladimir $u Palacky University, Faculty of Medicine, Olomouc, Czech Republic. Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Kromhout, Hans $u Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
700    1_
$a Vermeulen, Roel $u Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
700    1_
$a Boffetta, Paolo $u The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
700    1_
$a Straif, Kurt $u International Agency for Research on Cancer (IARC), Lyon, France.
700    1_
$a Schüz, Joachim $u International Agency for Research on Cancer (IARC), Lyon, France.
700    1_
$a Kendzia, Benjamin $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany.
700    1_
$a Pesch, Beate $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany.
700    1_
$a Brüning, Thomas $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany.
700    1_
$a Behrens, Thomas $u Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-Universität Bochum, Bochum, Germany.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 13, č. 2 (2018), s. e0192999
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29462211 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180710093004 $b ABA008
999    __
$a ok $b bmc $g 1316478 $s 1021268
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 13 $c 2 $d e0192999 $e 20180220 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...